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Abstract
Objective: The etiology of somatization is incompletely understood, but could be elucidated by models of
psychosocial stress. Academic exam stress has effectively been applied as a naturalistic stress model, however its
effect on somatization symptoms according to ICD-10 and DSM-IV criteria has not been reported so far. Baseline
associations between somatization and personality traits, such as alexithymia, have been studied exhaustively.
Nevertheless, it is largely unknown if personality traits have an explanatory value for stress induced somatization.
Methods: This longitudinal, quasi-experimental study assessed the effects of university exams on somatization —
and the reversal of effects after an exam-free period. Repeated-observations were obtained within 150 students,
measuring symptom intensity before, during and after an exam period, according to the Screening for Somatoform
Symptoms 7-day (SOMS-7d). Additionally, self-reports on health status were used to differentiate between medically
explained and medically unexplained symptoms. Alexithymia, neuroticism, trait-anxiety and baseline depression were
surveyed using the Toronto-Alexithymia Scale (TAS-20), the Big-Five Personality Interview (NEO-FFI), the State Trait
Anxiety Inventory (STAI) and Beck’s Depression Inventory (BDI-II). These traits were competitively tested for their
ability to explain somatization increases under exam stress.
Results: Somatization significantly increased across a wide range of symptoms under exam stress, while health
reports pointed towards a reduction in acute infections and injuries. Neuroticism, alexithymia, trait anxiety and
depression explained variance in somatization at baseline, but only neuroticism was associated with symptom
increases under exam stress.
Conclusion: Exam stress is an effective psychosocial stress model inducing somatization. A comprehensive
quantitative description of bodily symptoms under exam stress is supplied. The results do not support the stress-
alexithymia hypothesis, but favor neuroticism as a personality trait of importance for somatization.
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Introduction
Somatization has been defined as the “tendency to
experience and communicate somatic distress in response to
psychosocial stress and to seek medical help for it” [1].
Although the re-definition of somatization as a clinical concept
and its classification under the psychiatric category “somatic
symptom disorders” is a matter of ongoing debate [2] there is
consensus that medically unexplained symptoms (MUS) and a
stress-related etiology belong to its core features.
Somatization and personality traits – Is alexithymia the
key concept?
The causes of somatization have been hypothesized to be
multifactorial, involving several mechanisms (for review see:
[1,3,4]). Evidence suggests co-occurrence and shared
mechanisms with negative affect, anxiety [5], neuroticism [6,7]
and alexithymia [8]. Especially alexithymia, the inability to
identify, describe and differentiate emotions, has attracted
considerable attention as a potential predisposing factor for
somatization (for review see: [9]). However, the belief that
alexithymia causes or contributes to somatization is mainly
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based on cross-sectional studies, which do not allow causal
inferences [8,9]. Several authors therefore underlined the need
for more longitudinal studies [8–10]. Mechanistically,
alexithymia has been hypothesized to affect somatization by
modulating physiological responses to stress [11]. Although
this “stress-alexithymia hypothesis” has been experimentally
tested on measures of autonomic reactivity [12,13], its
relevance for somatization induced by a naturalistic
psychosocial stressor has, to our knowledge, not been tested
to date.
The effects of exam stress on somatization are
unknown
The effectiveness of exam stress as a model of psychosocial
stress has repeatedly been shown on immunological [14–16],
neuroendocrine [16,17], physiological and psychological
[18–21] parameters. Despite these associations, exam stress
has not been used to investigate predisposing factors of
somatization so far. To our knowledge only Koh and colleagues
(2006) [21] determined the effects of exam stress on
somatization, showing a significant positive relationship in 38
participants. Still, no quantitative description of somatization
symptoms under exam stress is available, although the somatic
symptoms of acute exam anxiety have been assessed
systematically [22,23].
The present study investigated somatization by exploring
increases in MUS as a reaction to naturalistic psychosocial
stress and by competitively testing the explanatory value of
several personality traits including alexithymia.
Our first aim was to provide a quantitative description of
somatic symptom increases under exam stress including all 53
physical symptoms from the somatization symptom lists of
ICD-10 and DSM-IV. It was hypothesized that an exam period
would affect total symptom scores, as well as distinct
symptoms. Both were expected to increase under exam stress
and return to baseline after a period without exams.
Our second aim was to test the predictive value of
alexithymia and such related concepts as neuroticism, trait
anxiety and depression for increases in somatization under
exam stress. It was hypothesized that alexithymia would
correlate positively with somatic symptom increases during
exam stress, according to the stress-alexithymia hypothesis,
and show a stronger association with these increases than
neuroticism, state anxiety, or depression.
Methods
The study was approved by the ethics committee of the
University of Regensburg and conforms to the Declaration of
Helsinki. Informed consent was obtained. Data were collected
and analyzed pseudonymously. Written informed consents
were obtained.
Study design
We conducted a longitudinal, quasi-experimental study with
a natural event, a reversal period and several control variables.
The natural, predictive event was defined as a major university
exam. Since exam types vary between academic disciplines,
this was specified as an exam being prerequisite for
graduation, or contributing to the university degree. Since
exams are often clustered, the most fearsome and/or
distressing exam according to participants’ choice was
selected. The intervention reversal period was defined as a
subsequent exam-free period of 30 days. Repeated
observations were obtained at three times within participants:
before (pre-baseline) and immediately after the predictive exam
(exam period), as well as after reversal period (post-baseline).
To guarantee that exam stress did not affect baselines, data
was only included when participants reported no exam within
the last and next 30 days. Moreover, to assure that the effect of
the exam was maximal, data for exam period was excluded
when participants failed to submit their survey within 3 days.
Figure 1 provides an overview of the study’s time course.
To increase internal validity, additional control measures
were recorded: acute infections, injuries or exacerbations of
pre-existing conditions, i.e. medically explained symptoms
(MES), pose an obvious alternative explanation for increases in
symptom reports. Therefore, descriptive participant reports of
current health status were surveyed, categorized and
subsequently tested for effects of exam period. Additional
measures of stress, state-anxiety and negative mood were
taken to reassure that exam period was an effective
psychosocial stressor.
Participants
For the present study 150 students of the University of
Regensburg and the Regensburg University of Applied
Sciences were recruited systematically across all faculties by
advertisement via bulletins, flyers and personal appeal at
academic lectures. Investigators’ relatives, friends and
colleagues were excluded from participation. Past or present
internal, neurological, hormonal or psychiatric disorders were
evaluated in a structured interview at study inclusion.
Participants with acute conditions and in medical treatment
were excluded from participation. Individuals with past or
chronic disorders in stable remission were included, but their
status was addressed as a potential confound in analysis.
Participants received a compensation of 8 Euros per hour.
Procedure
The only study visit was scheduled at least 30 days before
the first major exam. Written informed consent, medical history
and exam dates were obtained. If necessary, exam dates were
followed up by telephone interview and participants were
advised to report any exams that had to be re-scheduled. In
addition, exam dates were retrieved at the end of the post-
baseline session. All questionnaires were obtained using online
forms. Each participant received an e-mail containing a web-
link to an online platform and instructions on the day of study
visit one (pre-baseline), the day of the selected exam (exam
period) and one month after the last exam according to the
participant’s specifications (post-baseline) (see Figure 1). All
online-questionnaires were identical to the paper versions, with
the exception that missing items were prohibited by forced-
choice settings.
Somatic Symptoms Evoked by Exam Stress
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e84911
First Aim – State Questionnaires
Symptom intensities of 53 physical symptoms from the
somatization symptom lists of ICD-10 and DSM-IV were
measured according to the Screening for Somatoform
Symptoms 7-day version (SOMS-7d) [24,25], with the
difference that instructions asked participants to report
perceived impairment for all symptoms, without requesting
participants to differentiate between MUS and MES. The
SOMS-7d was designed to measures impairment by 53 typical
somatization symptoms, such as “headache”, “bloating” or
“back ache” on a 5-point Likert-scale within the last seven
days: Scores are 0 (symptom absent or not impairing), 1 (mild),
2 (medium), 3 (severe) and 4 (very severe). SOMS-7d
“symptom index” was the main outcome measure, calculated
by summation of all items [24–26].
Four custom items surveying current health status within the
last seven days were used to differentiate between MES and
MUS: Item one asked if the participant was feeling healthy
today. Item two asked if medical treatment or counsel had
recently been taken. Item three asked for the occurrence of any
disease or injury and item four for exacerbations of pre-existing
conditions. If any item was answered with “yes”, participants
were required to enter a detailed description of their condition
and symptoms into an open form field. Based on these items
and responses, three of the authors (M.Z., H.E., V.B.)
independently categorized sessions as “evidence for MES”
(yesMES), or “no evidence for MES” (noMES). Where raters’
categorization did not match, sessions were classified as
yesMES. This approach to differentiate between MES and
MUS was chosen to preclude that the causal attribution of
participants could bias somatization scores.
The Perceived Stress Questionnaire (PSQ-20) [27] was used
to confirm that the exam period was perceived as stressful. The
PSQ-20 is a shortened, German adaptation of the original
PSQ-30 [28], with good reliability (Cronbach’s alpha >.80).
Perceived stress is measured using 20 negatively and
positively worded items, such as “Your problems seem to be
piling up”, “You have trouble relaxing”, or “You have enough
time for yourself”. Items are rated on a 4-point likert scale (1
“almost never”, 2 “somtimes”, 3 “often”, 4 “usually”) [27].
The German versions of the State-Trait Anxiety Inventory –
State Form (STAI-G-X1) [29] and Beck’s Depression Inventory
II (BDI-II)[30], were used to survey state anxiety and
depression levels at all time-points as an intervention check.
For consistency, the BDI-II was adapted to a time-span of
seven days.
Second Aim – Trait Questionnaires
Alexithymia and three competing explanatory personality
traits were examined for their explanatory value for SOMS-7d
scores: The 20-item version of the Toronto-Alexithymia Scale
(TAS-20) [31–33] was the primary measure of alexithymia with
respect to our second aim. The TAS-20 surveys alexithymia on
the three dimensions “Difficulty identifying feelings”, “Difficulty
describing feelings” and “Externally oriented thinking style”. It
uses negatively and positively worded items like: “I’m often
confused about what emotion I am feeling”, “I am able to
describe my feelings easily” and “Being in touch with emotions
is essential”. Items are rated on a five-point Likert scale ranging
from 1 (strongly disagree) to 5 (strongly agree). From the
perspective of test- and measurement theory the 20-item
version of the TAS-20 is the most robust and time-economic
instrument to measure Alexithymia currently available.
However it has been criticized for its lack of discriminative
validity and the fact that it requires a self-evaluation — the very
feature alexithymia individuals are impaired in by definition
Figure 1.  Timeline.  
doi: 10.1371/journal.pone.0084911.g001
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[34–36]. Although defined as a trait measure, we collected the
TAS-20 at all three time-points, to follow up reports on its
doubtful temporal stability as a side-aim [37]. For all other
analyses the post-baseline score of the TAS-20 was used.
Trait-anxiety was surveyed using the State-Trait Anxiety
Inventory – Trait Form (STAI-G-X2) [29]. Trait neuroticism was
measured by using the Big Five Personality Inventory NEO-FFI
[38]. Trait depression was defined as the mean BDI-II score of
both baselines. Although the BDI-II is mostly used as a
measure of state depression it has been reported to accurately
assess trait-like characteristics [39].
Statistics
Statistics were processed with SPSS 21.0.0.0 for Mac OS
(Statistical Product and Service Solutions Inc., Chicago, IL,
USA), graphs were created using GraphPad Prism 5.0
(GraphPad Software, Inc, La Jolla, CA, USA). Statistical tests
were performed at a two-tailed α<.05. Means are given
±standard deviation if not denoted otherwise.
For aim one, a mixed linear model was used to estimate the
effect of fixed factor TIME with the levels pre-baseline, exam
and post-baseline on SOMS-7d symptom index, using SPSS’s
GENLINMIXED function. To control for potential confounds,
fixed factors MES with the levels yesMES and noMES, as well
as factor DISORDER with levels yesDIS (i.e. stable past or
chronic disorders) and noDIS (i.e. no disorders reported) were
included into the model. To account for individual differences in
SOMS-7d intensity score, a random intercept was added for
each participant. An autoregressive covariance matrix (AR1)
was used to model repeated covariance within sessions.
Robust estimation options and Satterthwaite-approximation
were used to account for potential violations of model
assumptions and correction of the estimated degrees of
freedom for unequal sample sizes. The SPSS’s syntax for this
basic model was added to Supplement S1. The mixed model
allows analyzing repeated-measures data without list-wise
exclusion of missing values. Therefore all sessions meeting the
deadlines in respect to past/upcoming exams were included in
the analysis, even when a participant missed one or two
sessions or deadlines.
All other control variables besides MES were tested for
effects of TIME analog to the linear mixed model for
somatization scores.
For MES, a chi-square test was used to determine if the
proportion of reported infections/injuries during exam period
differed from baselines.
Further the mixed model described above was applied to
address the question if the TAS-20 is a stable trait measure
over TIME. In addition inter- (Pearson’s correlation coefficient)
and intra-class correlations (ICC) for the TAS-20 were
computed.
Friedman’s tests were used for an item-by-item analysis of
the SOMS-7d in order to identify symptoms increasing during
exam period. For this item analysis an adapted α-Level of .001
was used to control for multiple-comparisons, and post-hoc
Wilcoxon’s paired rank tests were performed to confirm
increases between exam period and at least one baseline.
Aim two was to identify the best explanatory trait variable for
somatic symptoms at baseline and symptom increase under
exam stress. Traits were alexithymia (TAS-20), neuroticism
(NEO-FFI), trait anxiety (STAI-X-2) and trait depression (BDI-
II).
First, a correlation table using Kendall’s tau-b was created to
explore monotonous relationships. Kendall’s tau-b is the non-
parametric correlation coefficient of choice for symptom rating
scales, especially when comparisons are made between (sub-)
samples of different size [40]. For correlational analysis,
symptom index at baseline was defined as the mean of both
baseline sessions and somatization increase was defined as
symptom index during the exam period minus baseline.
Correlation analysis was followed by a modeling approach to
determine the best trait predictor of somatization symptoms.
Eight variants of the basic model described above (TIME, MES
and DISORDER (df1=4)) were compared: Four models were
created by adding one of the trait variates ALEXITHYMIA,
NEUROTICISM, ANXIETY or DEPRESSION (df1=5). Four
further models included the respective first-degree trait-by-
TIME interaction (df1=7) in addition. An individual random slope
parameter for each trait variate was added to each model to
keep the random effects structure of the model “maximal” [41].
The model syntax for this analysis is given in Supplement S1.
Finally, Akaike’s Information Criterion for finite sample sizes




Figure 2 gives an overview of participant flow. Analysis was
based on 142 participants (71 male, 71 female), of which 107
contributed three, 26 two and 9 one valid session(s). Mean age
at study inclusion was 22.2±2.5 (range: 18-33) years.
Participants with past or chronic internal, neurological and
psychiatric disorders in stable remission constituted 11% (8
male, 8 female) of the sample. The mean number of exams
reported was 4.9±2.1, ranging from 1 to 12. At mean, the exam
survey was submitted 1.0±1.6 days after the exam defined as
the intervention. For additional sample information see
Supplement S1.
Effects of Exam Stress on Somatization
In summary, the symptom index and all intervention check
variables assessing stress, depression and state anxiety were
found to significantly increase during the exam period
compared to both pre- and post-exam baselines. Inclusion of
the factors MES and DISORDER significantly improved model
fit for the prediction of symptom index (Δdf1=+2, ΔAICc=-20.29)
and most control variables. Descriptive results are shown in
Table 1, the corresponding linear mixed model results are
shown in Table 2.
A chi-square test indicated that the proportion of participants
reporting acute infections and/or injuries (evidence for MES)
during exam period (8.1%) was significantly lower (df=2,
χ2=7.45, p=.024) than at pre- (19.1%) and (18.6%) and post-
exam baseline.
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Almost all participants (95.0%) reported at least one
symptom causing mild impairment according to the combined
ICD-10 and DSM-IV list at baseline. The cumulative
proportions of participants reporting at least one moderate,
severe, or very severe symptom were 64.9%, 28.6% and 2.7%
respectively. These proportions increased under exam stress
(mild: 97.6%, medium: 80.5%, severe: 51.2%, very severe:
16.3%). The eleven SOMS-7d items listed in Table 3 were
found to be significantly elevated under exam stress according
to Friedman’s-tests and post-hoc tests at α≤.001. A full
description of results for all SOMS-7d –items is available online
(see: Table S1).
The explanatory value of personality traits on stress
induced somatization
Mean TAS-20 baseline score was 44.9±9.5 and therefore
roughly 4 units below norm values for the German population
[33]. Accordingly, only 8.9%, or 19.3%, of participants reached
a TAS-20 score of 61 or 52.5 — cut-off values suggested for
the diagnosis of “alexithymic” [33]. The significant differences in
mean response found for TAS-20 sum scores over time (see
Table 2) were followed up by computing Pearson’s coefficient
and the intra-class correlation coefficient (ICC): Correlations
were r=.788 for Survey 1 and 2, r=.804 for Survey 2 and 3 and
Figure 2.  Participant flow-chart.  
doi: 10.1371/journal.pone.0084911.g002
Table 1. The effects of exam period on measures of somatic symptoms and stress: Descriptive results.
 Pre-baseline Exam period Post-baseline
 n=141 n=123 n=118
 Mean±SD
Primary variable:
SOMS-7d 11.1±8.9 18.2±14.5 9.7±9.0
Control variables:
PSQ-20 33.6±17.5 54.0±19.3 29.8±18.3
BDI-II 6.6±6.4 11.5±7.0 5.2±5.4
STAI-G-X1 state 36.9±8.1 42.74±12.3 37.1±10.3
Side aim: Temporal stability of the TAS-20
TAS-20 45.3±9.7 45.9±10.1 44.6±10.2
Abbreviations: BDI-II: Beck’s Depression Inventory; PSQ-20: Perceived Stress Questionnaire; SOMS-7d: Screening for Somatoform Symptoms 7-day version; STAI-G-X1
state: State-Trait Anxiety Inventory – State Form; TAS-20: Toronto Alexithymia Scale 20-item version.
doi: 10.1371/journal.pone.0084911.t001
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Table 2. The effects of exam period on measures of somatic symptoms and stress: Mixed model results.
 Model Coefficient estimates
 df1=4 β±SEM
Primary variable:
SOMS-7d df2=6, F=18.92, p<.001 βExam=8.89±1.06, t=8.42, p=.009
  βpreBL=1.77±0.69, t=2.553, p=.012
  βMESyes=2.44±1.11, t=2.20, p=.032
  βyesDIS=7.63±3.15, t=2.42, p=.076
Control variables:
PSQ-20 df2=168, F=55.68, p<.001 βExam=24.22±1.95, t=12.45, p<.001
  βpreBL=3.98±1.65, t=2.410, p=.017
  βyesMES=0.27±2.12, t=0.13, p=.899
  βyesDIS=15.20±4.25, t=3.58 p=.001
BDI-II df2=63, F=37.02, p<.001 βExam=6.60±0.61, t=10.80, p<.001
  βpreBL=1.69±0.50, t=3.17, p=.003
  βyesMES=1.04±0.67, t=1.55, p=.124
  βyesDIS =4.49±1.54, t=2.92, p=.005
STAI-G-X1 state df2=68, F=10.34, p<.001 βExam=5.86±1.19, t=4.92, p<.001
  βpreBL=0.79±0.90, t=0.88, p=.930
  βyesMES=0.69±1.20, t=0.58, p=.566
  βyesDIS=6.32±2.40, t=2.63, p=.011
Side aim: Temporal stability of the TAS-20
TAS-20 df2=377, F=2.71, p=.030 βExam=1.80±0.60, t=3.00, p<.003
  βpreBL=0.79±0.56, t=1.41, p=.164
  βyesMES=0.46±0.93, t=0.49, p=.623
  βyesDIS=4.14±3.18, t=1.30, p=.359
All linear mixed models included factors TIME (pre-baseline, exam, post-baseline), MES (yesMES, noMES) and DISORDER (yesDIS, noDIS) and assumed a normal
distribution. Degrees of freedom (df2) may vary due to inequal sample sizes and the Satterthwaite approximation used. All analyses were based on 142 subjects contributing
382 data-points. Abbreviations: BDI-II: Beck’s Depression Inventory; GLM: Generalized Linear Model; MES: Medically Explained Symptoms; preBL: pre-baseline; PSQ-20:
Perceived Stress Questionnaire; SOMS-7d: Screening for Somatoform Symptoms 7-day version; STAI-G-X1: State-Trait Anxiety Inventory – State Form; TAS-20: Toronto
Alexithymia Scale 20-item version; yesDIS: With stable past/chronic disorders; yesMES: Evidence for MES.
doi: 10.1371/journal.pone.0084911.t002
Table 3. Results for somatization items significantly increasing under exam stress.
Item Symptom Pre-baseline Exam period Post-baseline Relative increase in prevalence Exam effect
     any severe  
  n=141 n=123 n=117  df=2
  Mean±SD % of baseline Χ2F, sig
1 Headache 0.82±0.92 1.33±1.11 0.71±0.78 30.7 258.8 26.70, ****
2 Abdominal pain 0.65±0.89 0.93±0.98 0.64±0.79 30.7 123.1 14.91, ***
3 Back pain 0.71±0.86 1.24±1.12 0.75±0.84 29.0 474.3 26.85, ****
4 Joint pain 0.33±0.69 0.59±0.88 0.34±0.64 53.2 76.5 14.17, ***
10 Nausea 0.45±0.71 0.76±0.90 0.41±0.66 53.8 317.8 23.64, ****
12 Discomfort/churning around stomach 0.72±0.94 1.24±1.10 0.54±0.83 79.8 199.5 43.44, ****
17 Loss of appetite 0.30±0.68 0.67±0.97 0.22±0.59 136.2 222.9 26.36, ****
20 Frequent diarrhea 0.22±0.60 0.50±0.91 0.19±0.53 105.3 227.9 14.24, ***
30 Excessive tiredness after mild exertion 0.50±0.85 1.03±1.21 0.37±0.62 66.7 487.5 29.88, ****
32 Sexual indifference 0.35±0.69 0.57±0.83 0.23±0.55 80.9 164.8 16.08, ***
Symptoms were surveyed according to the Screening for Somatoform Symptoms 7-day version (SOMS-7d). Effects of exam period were tested using Friedman’s test (Χ2F).
The alpha-Level was set to p≤.001 to correct for multiple comparisons. Significant results are depicted as **** p≤.0001, *** p≤.001. All post-hoc differences between
baselines and exam period were significant as tested with Wilcoxon’s paired rank tests (results not shown). Increases in symptom prevalence are shown in % of valid cases
for any severity (score≥1) and severe/very severe only (score≥3) at baseline.
doi: 10.1371/journal.pone.0084911.t003
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r=.787 (all p<.001) for Survey 1 and 3. Single ICC was .786,
mean ICC .917.
NEO-FFI-neuroticism scores [38] were close to normal
values with a mean of 21.0±7.2 points. Mean BDI-II score was
6.0±5.2 and therefore 4 units below a normal student sample
[43]. STAI-G-X2 trait anxiety scores were at 39.2±8.7 points
and therefore 4 units above a normal student sample [29].
Correlations between somatic symptoms and trait variables
according to Kendall’s τ-b are shown in Table 4. NEO-FFI-
neuroticism was the only significant trait that correlated with
somatic symptom increase during exam period, showing a
positive monotonous relationship. All trait variables correlated
with symptom index at baseline. All trait variables were
considerably inter-correlated.
An information theory driven model selection approach was
applied to determine the best explanatory trait variable for the
obtained somatization scores. AICc weights indicated that the
basic model plus NEUROTICISM and NEUROTICISM*TIME
(df1=7) was the best-fitting model, with a probability of 0.97
relative to all equal or smaller models according to Akaike
weights. The second-best model was the basic model plus the
main effect of NEUROTICISM only, with a probability of only .
03. The competing models with TAS-20 and TAS-20*TIME
(ΔAICc=+31.59), STAI-G-X2 and STAI-G-X2*TIME (ΔAICc=
+105.22) and BDI-II and BDI-II*TIME (ΔAICc=+81.93) had only
marginal likelihoods of being the best-fitting model.
The final model (F=14.63, df1=7, df2=6, p=.002) showed a
significant main effect of NEUROTICISM (β=0.44±0.10(SEM),
t=4.34, p<.001) and MES (β=2.55±1.20(SEM), t=2.10, p=.039),
as well as a positive interaction between NEUROTICISM and
TIME (F=5.54, df1=2, df2=10, p=.025), driven by a significant
interaction of coefficients NEUROTICISM*exam period
(β=0.42±0.13(SEM), t=3.30, p=.020). The factor DISORDER
fell short of the criterion of significance (F=2.58, df=16, p=.128),
which was also missed by all other coefficients. A graphical
display of the relationship between symptom index,
NEUROTICISM and TIME is given in Figure 3.
The models including TAS-20 (F=16.39, df1=7, df2=3, p<.
017), STAI-G-X2 (F=15.01, df1=7, df2=7, p<.001) and BDI-II
(F=16.76, df1=7, df2=8, p<.001) were all explaining a significant
amount of variance, however the coefficients TAS-20*exam
period (β=0.101±0.12(SEM), t=0.86, p=.553), STAI-G-X2*exam
period (β=0.31±0.13(SEM), t=2.46, p=.147) and BDI-II*exam
period (β=0.41±0.23(SEM), t=1.78, p=.183) failed to do so.
Original data for the present results have been made publicly
available as a download. However, the following changes to
the raw data file were made: Birthdate, exam date, date of
study inclusion, information on illicit drug use, subject of study,
original description of medical history and original description of
current illness/injuries were deleted and/or replaced by
summary variables to ensure participant’s privacy.
Discussion
This quasi-experimental study was conducted to provide a
comprehensive quantification of somatic symptoms under
exam stress in healthy students and to evaluate whether
personality traits like alexithymia can explain their occurrence.
Exam stress increases somatization — typical
symptoms
During an exam period symptom scores showed highly
significant increases compared to pre- and post-baselines,
even when accounting for participant reports of infections/
injuries and pre-existing disorders statistically. This was
paralleled by increases in perceived stress, depression and
anxiety. These findings confirm that academic exam periods
represent an effective model for psychosocial stress, with a
significant impact on somatization. Bodily complaints increased
across several domains encompassing pain, gastro-intestinal
and autonomic symptoms. Significant increases during the
exam period were mainly found for symptoms with a high
prevalence at baseline, e.g: headache, back pain, abdominal
pain, and nausea. An exception of this trend was bloating,
which did not significantly increase although being one of the
most common symptoms. The symptom with the highest
absolute increase in prevalence across all severities was
discomfort/churning around the stomach, which is synonymous
to the proverbial “butterflies in the stomach” commonly
associated with exams. However, the symptoms with the
highest relative increases in prevalence were loss of appetite,
frequent diarrhea and sexual indifference. These can therefore
be recommended as the most target specific symptoms of
exam stress for future studies. Finally, the symptoms with the
strongest relative increases when counting severe/very severe
ratings only, were excessive tiredness after mild exertion, back
Table 4. Correlations between somatic symptoms at baseline, somatic symptom increase during an exam period and
personality traits.
 SOMS-7d baseline SOMS-7d increase TAS-20 alexithymia NEO-FFI neuroticism STAI-G-X2 trait anxiety
SOMS-7d increase n=134, τ=.074, p=.212     
TAS-20 alexithymia n=132, τ=.228, p<.001 n=131, τ=-.050, p=.412    
NEO-FFI neuroticism n=132, τ=.359, p<.001 n=131, τ=.152, p=.012 n=132, τ=.270, p<.001   
STAI-G-X2 trait -anxiety n=142, τ=.295, p<.001 n=134, τ=.074, p=.212 n=132, τ=.319, p<.001 n=132, τ=.514, p<.001  
BDI-II baseline depression n=142, τ=.413, p<.001 n=134, τ=.066, p=.271 n=132, τ=.327, p<.001 n=132, τ=.470, p<.001 n=142, τ=.482, p<.001
All tests were performed using Kendall’s τ-b. Abbreviations: BDI-II: Beck’s Depression Inventory; NEO-FFI: Big Five Personality Inventory, Neuroticism Subscale; SOMS-7d:
Screening for Somatoform Symptoms 7 day version; STAI-G-X2: State-Trait Anxiety Inventory – Trait Form; TAS-20: Toronto Alexithymia Scale, 20-item version.
doi: 10.1371/journal.pone.0084911.t004
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pain, nausea and headache, indicating that these are the exam
stress related symptoms perceived as the most impairing.
The differentiation of MES and MUS poses a challenging
problem in the study of somatization [44]. Reports of infections
and injuries were obtained in the present study to account for
the effects of MES statistically. In addition these reports were
found to significantly decline during exam period by about half,
while predicting increased somatization symptom scores
across all sessions. This decrease in MES may be explained
by the well-known temporary immune-enhancing effects of
acute stressors [45], as well as reductions in social and/or
physical activity during the exam preparation period.
Figure 3.  The relationship between trait neuroticism, somatic symptoms at baseline and under exam stress.  There was a
significant interaction between NEUROTICISM and exam period (β=0.42±0.13(SEM), t=3.30, p=.020), even when accounting for
medically explained symptoms and pre-existing disorders. Raw data are shown and simple linear interpolation lines were added for
illustrative purposes. To reduce overlap, data points for pre- and post- baseline were shifted by -0.5 and +0.5 points along the x-
axis, respectively,
doi: 10.1371/journal.pone.0084911.g003
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Neuroticism is associated with somatization increases
under stress
Neuroticism was found to explain a significant amount of
variance in somatization under exam stress. Participants with
high trait neuroticism scores showed higher symptom scores in
general and higher symptom increases under exam stress.
This finding replicates previous reports of baseline correlations
between neuroticism and somatic symptoms [5,7,46,47] and
extends them by showing that neuroticism can explain stress-
induced somatization. Neuroticism has been investigated as
personality trait moderating stress reactivity since a long time.
It has been linked to differences in the appraisal of a stressor,
as well as the reactivity to a stressor. Further it has been
discussed in conjunction with differences in stress coping
behaviors and even differences in exposure to stressors
[48,49]. All of these influences might account for the observed
relationship.
No support for the stress-alexithymia hypothesis
Although the present study could replicate findings that TAS-
alexithymia (for review see: [9]), trait anxiety and baseline
depression [5] are positively associated with somatization at
baseline, no such relationship could be found for increases in
somatization under exam stress. Compared to neuroticism,
TAS-alexithymia, anxiety and baseline depression had only a
marginal likelihood of being the best explanatory variable for
the observed variance in symptom index. These results do not
support our second hypothesis, which claimed that alexithymia
would be a significant and superior explanatory variable for
exam stress induced somatization. This finding is in agreement
with experimental studies, which reported that alexithymia was
not associated with an increased reactivity to physiological
measures of stress [12,50]. Further our results are in line with a
longitudinal study, which could not find a predictive value of
alexithymia for the persistence of unexplained physical
symptoms in general medical outpatients [51]. In accord with
earlier conclusions [52], our results point out that alexithymia
and somatization might not be linked by a difference in
reactivity to acute stress in the general population. It must be
emphasized that exam stress is only one specific form of
psychosocial stress. The link between alexithymia and stress
reactivity might be different for other forms of psychosocial
stress, such as long-term interpersonal stress. Moreover, the
role of alexithymia might be different in patient samples, or
highly alexithymic sub-populations.
On the temporal stability of the TAS-20
The temporal stability of the TAS-20, especially in clinical
samples and under conditions of psychological distress, has
been a matter of discussion [37]. In the present study,
significant differences in TAS-20 between session 2 and 3, but
not 2 and 1 could be found. This result somewhat confirms
reports of a state- and probably stress dependent proportion of
TAS-20 scores [37,53]. However, the small size of session-to-
session differences during a period of increased stress leads
us to the conclusion that the TAS-20 is a reliable trait measure
with only minor state confounds. Pearson’s correlation
coefficients computed and a ICC computed for all three survey
time-points confirm this notion by indicating an acceptable re-
tests reliability of r>.75.
Limitations
Two baselines, before and after exam period, were included
in the present study. Since all psychometric scores returned to
normal at post-exam baseline, it can be ruled out that the
observed increases reflect simple time effects. A number of
control variables showed parallel effects for measures of
distress (stress, depression and anxiety) and a reduction in
infection and/or injuries, which confirms that the observed
effects are due to exam stress. MES were surveyed and
categorized to control for participant bias. Nevertheless,
several limitations apply to the present study and its
interpretation:
The main limitation of the present study is that a self-reports
bias, driven by social desirability might have confounded all
measures. Participants were aware of the study’s focus on the
effects of exam stress, since the retrieval of exact exam dates
would otherwise not have been possible. This might have in- or
deflated somatization reports during the exam period,
especially since it is known that students tend to bias
retrospective ratings of pre-exam distress in the direction that
maximizes self-esteem [54].
In addition, our sample size decreased with each survey.
This might have biased results towards a healthier student
sample. Differences between pre- and post- exam baselines
are therefore not discussed, since these might be explained by
drifts in sample characteristics and reduced stress levels alike.
Finally, the trait measures NEO-FFI and STAI-G-X2 have
been recorded only at pre- or post-baseline only, to reduce
participant’s timely efforts. Despite the high temporal stability of
the STAI-G-X2 [29], its comparability with the other trait
variables might be confounded by subtle state-differences
between the baselines and the mentioned change in sample
size.
Conclusion
Here we could show that somatization significantly increased
under exam stress across a range of symptom dimensions in
healthy university students. The present results verify that
transient increases in somatization can be evoked by
psychosocial stress. The dataset constitutes a valuable basis
for future studies on bodily symptoms under psychosocial
stress. Further the present findings could not support the
stress-alexithymia hypothesis. This highlights that studies in
search of personality factors predisposing for somatization
should always consider alternative explanatory concepts.
Neuroticism was identified as a better correlate of somatization
induced by acute exam stress than TAS-alexithymia, trait
anxiety or depression. Perceptions or behaviors related to
neuroticism might be of etiological importance for somatization
under psychosocial stress and pose interesting targets for
future studies.
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Supporting Information
Table S1.  SOMS items significantly increasing under exam
stress: Full results. Symptoms were surveyed according to
the Screening for Somatoform Symptoms 7 day (SOMS-7d).
Effects of exam period were tested using Friedman’s test (Χ2F).
The alpha-Level was set to ≤ 0.001 to correct for multiple
comparisons. Significant results are depicted as **** p ≤
0.0001, *** p ≤ 0.001. All post-hoc differences between
baselines and exam period were significant as tested with
Wilcoxon’s paired rank tests (results not shown). Increases in
symptom prevalence are shown in %of valid cases for any
severity (score ≥ 1) and severe/very severe only (score ≥ 3) at
baseline.
(DOCX)
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